STAND STUDY OF TRANSITIONING FROM ALENDRONATE TO DENOSUMAB Trademark

Trademark Overview

On Wednesday, October 11, 2006, a trademark application was filed for STAND STUDY OF TRANSITIONING FROM ALENDRONATE TO DENOSUMAB with the United States Patent and Trademark Office. The USPTO has given the STAND STUDY OF TRANSITIONING FROM ALENDRONATE TO DENOSUMAB trademark a serial number of 77018425. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 6, 2010. This trademark is owned by Amgen Inc.. The STAND STUDY OF TRANSITIONING FROM ALENDRONATE TO DENOSUMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely conducting clinical trials
stand study of transitioning from alendronate to denosumab

General Information

Serial Number77018425
Word MarkSTAND STUDY OF TRANSITIONING FROM ALENDRONATE TO DENOSUMAB
Filing DateWednesday, October 11, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 6, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2007

Trademark Statements

Disclaimer with Predetermined Text"ALENDRONATE or DENOSUMAB"
Goods and ServicesMedical and scientific research, namely conducting clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 16, 2006
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, December 6, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 6, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 11, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 10, 2010EXTENSION 5 GRANTED
Thursday, May 6, 2010EXTENSION 5 FILED
Thursday, May 6, 2010TEAS EXTENSION RECEIVED
Wednesday, October 28, 2009EXTENSION 4 GRANTED
Tuesday, October 27, 2009EXTENSION 4 FILED
Tuesday, October 27, 2009TEAS EXTENSION RECEIVED
Friday, April 10, 2009EXTENSION 3 GRANTED
Wednesday, April 8, 2009EXTENSION 3 FILED
Wednesday, April 8, 2009TEAS EXTENSION RECEIVED
Wednesday, November 5, 2008EXTENSION 2 GRANTED
Tuesday, November 4, 2008EXTENSION 2 FILED
Wednesday, November 5, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 4, 2008TEAS EXTENSION RECEIVED
Wednesday, April 23, 2008EXTENSION 1 GRANTED
Wednesday, April 16, 2008EXTENSION 1 FILED
Wednesday, April 16, 2008TEAS EXTENSION RECEIVED
Tuesday, November 6, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 14, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2007NOTICE OF PUBLICATION
Wednesday, July 11, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 5, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 29, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 29, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 28, 2007ASSIGNED TO LIE
Wednesday, June 20, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 22, 2006NON-FINAL ACTION E-MAILED
Friday, December 22, 2006NON-FINAL ACTION WRITTEN
Tuesday, December 19, 2006ASSIGNED TO EXAMINER
Monday, October 16, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

alendronate denosumab from transitioning study stand clinical trials conducting namely scientific research medical